Results 101 to 110 of about 5,502 (184)

A Longitudinal Analysis of Outcomes Associated with Abciximab and Eptifibatide in a Consecutive Series of 3074 Percutaneous Coronary Interventions

, 2007
Kirsten Hall Long, Henry H. Ting, Erin K. McMurtry, Ryan J. Lennon, Douglas L. Wood, David R. Holmes, Ganesh Raveendran, Charanjit S. Rihal   +7 more
openalex   +1 more source

Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery [PDF]

, 2016
Brent T. Boettcher, Timothy J. Olund, Paul S. Pagel   +2 more
openalex   +1 more source

Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients [PDF]

, 2017
Krishnaraj S. Rathod, Sotiris Antoniou, Parizad Avari, Nannan Ding, P Wright, C Knight, Arun K. Jain, Anthony Mathur, EJ Smith, Roshan Weerackody, Andrew Wragg, Daniel A. Jones   +11 more
openalex   +1 more source

Unraveling the role of the homoarginine residue in antiplatelet drug eptifibatide in binding to the αIIbβ3 integrin receptor.

Thrombosis Research, 2022
D. L. van den Kerkhof, M. Nagy, K. Wichapong, S. Brouns, D. Suylen, T. Hackeng, I. Dijkgraaf   +6 more
semanticscholar   +1 more source

CV2: EFFECTIVENESS AND COST-EFFECTIVENESS OF EPTIFIBATIDE IN INDIVIDUAL PATIENTS WITH ACUTE CARDIAC ISCHEMIA: THE IMPORTANCE OF RISK STRATIFICATION

, 2000
DM Kent, Robin Ruthazer, J R Beshansky, HP Selker   +3 more
openalex   +1 more source

Eptifibatide is noninferior to abciximab: implications for clinical practice [PDF]

, 2010
Alexandra King
openalex   +1 more source

Primary Percutaneous Coronary Angioplasty With and Without Eptifibatide in ST-Segment Elevation Myocardial Infarction [PDF]

, 2009
Michel R. Le May, George A. Wells, Chris Glover, Derek So, Michael Froeschl, Jean-François Marquis, Edward R. O’Brien, Michèle Turek, Allyson Thomas, Malek Kass, Sachin Jadhav, Marino Labinaz   +11 more
openalex   +1 more source

Early Percutaneous Coronary Intervention, Platelet Inhibition With Eptifibatide, and Clinical Outcomes in Patients With Acute Coronary Syndromes [PDF]

, 2000
Neal S. Kleiman, A. Michael Lincoff, Greg C. Flaker, Karen S. Pieper, Robert G. Wilcox, Lisa G. Berdan, Todd J. Lorenz, Dennis V. Cokkinos, Maarten L. Simoons, Eric Boersma, Eric J. Topol, Robert M. Califf, Robert A. Harrington   +12 more
openalex   +1 more source

Tolerability and feasibility of eptifibatide in acute coronary syndrome in patients at high risk for cardiovascular disease: A retrospective analysis

, 2005
Zaher S. Azzam, Elias Sa'ad, Amal Jab Jabareen, Oron Eilam, Petru Bartha, Salim Hadad, Norberto Krivoy   +6 more
openalex   +2 more sources

Prophylactic Intra-Arterial Eptifibatide in Stent-Assisted Coiling and Flow Diverter Treatment of Cerebral Aneurysms: A Single-Center Retrospective Analysis. [PDF]

J Clin Med
Gothelf I, Epstein M, Shiloh A, Lebowitz Z, Zlotnik Y, Sacho RH, Mechnik Steen Y, Ben-Arie G, Horev A.   +8 more
europepmc   +1 more source